c
2
12
18
28
12
12
1a
14
e
12
16
a
a
2
2
a
20
32
1a
2a
19
Faculty
61 16
19
1
49
2
2
1a
32
34
1b
1d
18
2e
3b
1d
2 29
1d
25
David A Wolk, MD
88
3b
Professor of Neurology
7
60
Department: Neurology
4
1
23
1f
Graduate Group Affiliations
8
b
-
41
- Bioengineering 64
- Neuroscience e
1d
46
Contact information
40
4
3
3
3
2
4
b
1f
40
Penn Memory Center
15 Ralston House
d #212A
37 3615 Chestnut Street
Philadelphia, PA 19104
26
15 Ralston House
d #212A
37 3615 Chestnut Street
Philadelphia, PA 19104
2e
Office: 215 662-7810
32 Fax: 215 662-7812
24
93
32 Fax: 215 662-7812
24
Email:
david.wolk@uphs.upenn.edu
12
david.wolk@uphs.upenn.edu
13
Education:
21 7 BA 17 (Psychology) c
2a Dartmouth College, 1994.
21 7 MD 15 (Medicine) c
44 Johns Hopkins University School of Medicine, 1998.
c
3
3
3
3
8f
Permanent link21 7 BA 17 (Psychology) c
2a Dartmouth College, 1994.
21 7 MD 15 (Medicine) c
44 Johns Hopkins University School of Medicine, 1998.
c
2 29
21
1e
1d
24
5e
e 29
27
Description of Research Expertise
b5 Episodic Memory, Event-related Potentials, transcranial direct current stimulation, MRI, Alzheimer's Disease, Dementia, Memory Disorders, Cognitive Neurology, Aging,e 29
23
1cc Wolk DA, Dickerson BC: Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 107(22): 10256-61, Jun 2010 Notes: Featured article in Alzheimer Research Forum: ApoE and Brain Networks—The Anatomy of a Risk Factor, May 28, 2010.
10e Wolk DA, Dunfee KL, Dickerson BC, Aizenstein HJ, Dekosky ST: A medial temporal lobe division of labor: Insights from memory in aging and early Alzheimer disease. Hippocampus 21(5): 461-6, Mar 2010.
130 Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, Klunk WE, DeKosky ST: Amyloid imaging in mild cognitive impairment subtypes. Annals of Neurology 65(5): 557-68, May 2009.
168 Dickerson BC, Wolk DA: MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology 78(2): 84-90, Dec 2011 Notes: Featured editorial on manuscript: Resnick SM; Scheltens P. MRI-based biomarkers of preclinical AD: An Alzheimer signature. Neurology: 78(2): 80-81. 2 8f Featured article in Alzheimer Research Forum. Is Structural MRI Closing In on Preclinical AD Biomarker? December 27, 2011.
127 Pluta J, Yushkevich P, Das S, Wolk D: In vivo Analysis of Hippocampal Subfield Atrophy in Mild Cognitive Impairment via Semi-Automatic Segmentation of T2-Weighted MRI. Journal of Alzheimer's Disease 31(1): 85-99, Jan 2012.
10e Wolk DA, Price JC, Madeira C, Saxton JA, Snitz BE, Lopez OL, Mathis CA, Klunk WE, Dekosky ST: Amyloid imaging in dementias with atypical presentation. Alzheimer's & Dementia 8(5): 389-98, Jan 2012.
101 Wolk DA, Mancuso L, Kliot D, Arnold SE, Dickerson BC: Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD. Neuropsychologia 51(6): 1094-102, Mar 2013.
2c
7
1d
1f
Selected Publications
c1 Wolk DA, Dickerson BC : Fractionating verbal episodic memory in Alzheimer's disease. NeuroImage 54(2): 1530-9, Sep 2010.1cc Wolk DA, Dickerson BC: Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 107(22): 10256-61, Jun 2010 Notes: Featured article in Alzheimer Research Forum: ApoE and Brain Networks—The Anatomy of a Risk Factor, May 28, 2010.
10e Wolk DA, Dunfee KL, Dickerson BC, Aizenstein HJ, Dekosky ST: A medial temporal lobe division of labor: Insights from memory in aging and early Alzheimer disease. Hippocampus 21(5): 461-6, Mar 2010.
130 Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, Klunk WE, DeKosky ST: Amyloid imaging in mild cognitive impairment subtypes. Annals of Neurology 65(5): 557-68, May 2009.
168 Dickerson BC, Wolk DA: MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology 78(2): 84-90, Dec 2011 Notes: Featured editorial on manuscript: Resnick SM; Scheltens P. MRI-based biomarkers of preclinical AD: An Alzheimer signature. Neurology: 78(2): 80-81. 2 8f Featured article in Alzheimer Research Forum. Is Structural MRI Closing In on Preclinical AD Biomarker? December 27, 2011.
127 Pluta J, Yushkevich P, Das S, Wolk D: In vivo Analysis of Hippocampal Subfield Atrophy in Mild Cognitive Impairment via Semi-Automatic Segmentation of T2-Weighted MRI. Journal of Alzheimer's Disease 31(1): 85-99, Jan 2012.
10e Wolk DA, Price JC, Madeira C, Saxton JA, Snitz BE, Lopez OL, Mathis CA, Klunk WE, Dekosky ST: Amyloid imaging in dementias with atypical presentation. Alzheimer's & Dementia 8(5): 389-98, Jan 2012.
101 Wolk DA, Mancuso L, Kliot D, Arnold SE, Dickerson BC: Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD. Neuropsychologia 51(6): 1094-102, Mar 2013.
2c
4d
22
22
7
10
a
a
2
2
19
18
10
22
10
11
c
5b © The Trustees of the University of Pennsylvania | Site best viewed a in a supported browser. | Site Design: 57 PMACS Web Team. 3 22
10